ASX 200 (ASX:XJO) midday update: Incitec Pivot and Mesoblast jump, NAB drops

The ASX 200 has started the week strongly…

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At lunch on Monday, the S&P/ASX 200 Index (ASX: XJO) is on course to start the week with a solid gain. The benchmark index is currently up 0.4% to 7,472.9 points.

Here's what is happening on the ASX 200 today:

Man looks shocked as he works on laptop on top a skyscraper with stockmarket figures in graphic behind him.

Image source: Getty Images

Incitec Pivot results impress

The Incitec Pivot Ltd (ASX: IPL) share price jumped as much as 17% this morning following the release of its full year results. As management promised, Incitec Pivot delivered a strong second half performance. This led to the agricultural chemicals company reporting a 10% lift in full year revenue to $4,348.5 million and 91% jump in net profit after tax (NPAT) excluding individually material items to $209 million. This was driven by a strong performance from its Fertilisers APAC business, which benefited from a commodity price upswing and strong ammonium phosphates production.

Mesoblast shares jump

The Mesoblast limited (ASX: MSB) share price is charging higher today after the allogeneic cellular medicines developer released positive data from a phase three trial of rexlemestrocel-L in 565 patients with New York Heart Association (NYHA) class II and class III chronic heart failure (CHF) with reduced ejection fraction (HFrEF). Among other things, the study notes that a single dose of rexlemestrocel-L on top of standard of care reduced the incidence of heart attacks or strokes by 65% across all 537 NYHA class II or class III treated patients compared with standard of care alone.

NAB shares fall

The National Australia Bank Ltd (ASX: ANZ) share price is trading lower on Monday. However, this has nothing to do with its performance. Today's decline is attributable to the banking giant's shares trading ex-dividend for its final dividend for FY 2021. Last week NAB declared a fully franked final dividend of 67 cents per share with its full year results. Eligible NAB shareholders can look forward to receiving this dividend on 15 December.

Best and worst ASX 200 performers

The best performer on the ASX 200 on Monday has been the Mesoblast share price with a 10% gain. This follows its trial update this morning. The worst performer on the ASX 200 has been the Ampol Ltd (ASX: ALD) share price with a decline of almost 3%. This is despite there being no news out of the fuel retailer.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

Winning woman smiles and holds big cup while losing woman looks unhappy with small cup.
Share Gainers

Here are the top 10 ASX 200 shares today

Another day, another loss for investors.

Read more »

a woman in a wheelchair sits at her desk in her home with headphones on and looking at a computer screen of figures. monitoring the CBA share price
Share Market News

Top 10 ASX shares bought and sold in April

Amid the fuel crisis and fears of a recession, here are the stocks that investors traded most.

Read more »

A smiling woman holds a Facebook like sign above her head.
Broker Notes

5 ASX shares scoring upgraded ratings this week

Experts have raised their ratings on JB Hi-Fi, Beach Energy, Amcor, and others this week.

Read more »

A woman has a thoughtful look on her face as she studies a fan of Australian 20 dollar bills she is holding on one hand while he rest her other hand on her chin in thought.
Share Market News

Should I sell my Telstra shares in May?

If I owned Telstra shares, here's what I'd do next.

Read more »

Magnifying glass on a rising interest rate graph.
Share Market News

Buying ASX shares? Here's what to expect from Tuesday's RBA interest rate meeting

Leading experts sound off on the RBA’s likely next interest rate move.

Read more »

A man sitting at his dining table looks at his laptop and ponders the share price.
Broker Notes

Down 65%: Is this ASX 300 stock a cheap buy?

This stock has been sold off. Has this created a buying opportunity? Let's see what Bell Potter is saying.

Read more »

Three guys in shirts and ties give the thumbs down.
Broker Notes

5 ASX All Ords shares downgraded by brokers this week

Brokers have reduced their ratings on PLS Group, Fortescue, Webjet, and others this week.

Read more »

A man sits in contemplation on his sofa looking at his phone as though he has just heard some serious or interesting news.
Broker Notes

Does Ord Minnett rate Goodman shares as a buy, hold, or sell?

The broker has been looking at a big agreement signed this month.

Read more »